Alexander Orest Subtelny, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Biosynthesis | 6 | 2020 | 2096 | 0.660 |
Why?
|
| Poly A | 3 | 2017 | 180 | 0.610 |
Why?
|
| RNA, Messenger | 7 | 2020 | 12813 | 0.490 |
Why?
|
| Amino Acids | 2 | 2011 | 1713 | 0.430 |
Why?
|
| RNA Stability | 4 | 2020 | 322 | 0.420 |
Why?
|
| Ribosomes | 2 | 2014 | 500 | 0.330 |
Why?
|
| Codon | 1 | 2011 | 598 | 0.320 |
Why?
|
| Peptides | 2 | 2011 | 4368 | 0.290 |
Why?
|
| Prostatectomy | 3 | 2020 | 1840 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3612 | 0.250 |
Why?
|
| MicroRNAs | 4 | 2020 | 3806 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2024 | 3198 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2011 | 506 | 0.150 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11206 | 0.140 |
Why?
|
| Drosophila melanogaster | 2 | 2018 | 1725 | 0.140 |
Why?
|
| Polyadenylation | 2 | 2017 | 116 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2020 | 1503 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2017 | 360 | 0.120 |
Why?
|
| Cystectomy | 1 | 2019 | 644 | 0.120 |
Why?
|
| Gastrulation | 1 | 2014 | 37 | 0.110 |
Why?
|
| Zygote | 1 | 2014 | 115 | 0.110 |
Why?
|
| Plant Leaves | 1 | 2014 | 153 | 0.110 |
Why?
|
| Yeasts | 1 | 2014 | 279 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2019 | 798 | 0.100 |
Why?
|
| Drosophila | 2 | 2017 | 1514 | 0.100 |
Why?
|
| Xenopus | 1 | 2014 | 710 | 0.100 |
Why?
|
| Zebrafish | 2 | 2014 | 3038 | 0.090 |
Why?
|
| Oocytes | 1 | 2016 | 1168 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2014 | 469 | 0.090 |
Why?
|
| Species Specificity | 1 | 2014 | 2419 | 0.080 |
Why?
|
| RNA, Transfer | 1 | 2011 | 284 | 0.080 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2008 | 4 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2020 | 1086 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2018 | 3442 | 0.070 |
Why?
|
| Pyruvate Kinase | 1 | 2009 | 190 | 0.070 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2008 | 136 | 0.070 |
Why?
|
| Base Sequence | 2 | 2018 | 12426 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2019 | 2254 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 2038 | 0.060 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3939 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4299 | 0.060 |
Why?
|
| 3' Untranslated Regions | 2 | 2018 | 514 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2018 | 527 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 7602 | 0.050 |
Why?
|
| Cell Line | 2 | 2014 | 15610 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3734 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2024 | 1335 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7575 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 9508 | 0.040 |
Why?
|
| Animals | 7 | 2020 | 169424 | 0.040 |
Why?
|
| Evolution, Molecular | 2 | 2018 | 1894 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 255 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2018 | 24310 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1163 | 0.030 |
Why?
|
| Mice | 3 | 2020 | 82051 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1781 | 0.030 |
Why?
|
| Survival Rate | 2 | 2019 | 12875 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2019 | 699 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2531 | 0.020 |
Why?
|
| Organogenesis | 1 | 2012 | 214 | 0.020 |
Why?
|
| Fructosediphosphates | 1 | 2009 | 24 | 0.020 |
Why?
|
| Humans | 10 | 2024 | 768369 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6537 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3586 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 30031 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2009 | 413 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4294 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39429 | 0.020 |
Why?
|
| Ovary | 1 | 2012 | 960 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7064 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 2680 | 0.020 |
Why?
|
| Glycolysis | 1 | 2009 | 838 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9376 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 1685 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 939 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 171514 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9425 | 0.010 |
Why?
|
| Male | 4 | 2023 | 364761 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 223406 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2024 | 23639 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11928 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 14157 | 0.010 |
Why?
|
| Glucose | 1 | 2009 | 4355 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40271 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5912 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59679 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65408 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81835 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 223528 | 0.000 |
Why?
|
| Female | 1 | 2012 | 396926 | 0.000 |
Why?
|